小摩增持信达生物(01801)约163.59万股 每股作价约90.91港元

Group 1 - The core point of the article is that JPMorgan has increased its stake in Innovent Biologics (01801) by purchasing 1,635,942 shares at a price of HKD 90.9102 per share, totaling approximately HKD 149 million [1] - After the purchase, JPMorgan's total shareholding in Innovent Biologics is approximately 87,161,800 shares, representing a holding percentage of 5.08% [1]